期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

选择性环加氧酶-2抑制剂在肿瘤防治中的研究进展

PROGRESS OF RESEARCH IN THE SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 FOR PROPHYLACTICO-THERAPEUTICS OF TUMOR
下载PDF
导出
摘要 介绍选择性环加氧酶(COX-2)抑制剂的研究现状,探讨肿瘤防治的新方法。选择性COX-2抑制剂用于肿瘤的防治是一种较理想的方法。选择性COX-2抑制剂用于肿瘤的防治有广阔的前景,尚有许多问题需进一步研究。 To introduce the recent study on the selective inhibitor of cyclooxygenase - 2 （ COX - 2） and to explore the new methods of prophylactico - therapeutics of tumor. The selective inhibitor of COS - 2 is a more ideal method in prophylactico - therapeutics of tumor. The selective inhibitor of COX - 2 has a wide future in the prophylactico - therapeutics of tumor, but many problems need to be solved in future.
作者 李志祥 李秀霞
机构地区 内蒙古医学院病理教研室
出处 《内蒙古医学院学报》 2007年第4期305-308,共4页 Acta Academiae Medicinae Neimongol
关键词 COX-2抑制剂 肿瘤防治 inhibitor of cyclooxygenase - 2 prophylactico - therapeutics of tumor
分类号 R971.1 [医药卫生—药品]
  • 相关文献

参考文献21

  • 1李玉林.病理学[M].第六版,北京:人民卫生出版社,2003:92
  • 2刘莹,朱祖安,费素娟.COX-2 iNOS及VEGF在胃不典型增生胃癌中的表达及其意义[J].中国肿瘤临床,2005,32(8):428-430. 被引量：9
  • 3Akiuchi Y,Tsuji S,Tsujii M,et al.Cyclooxygenase -2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis[J].Cancer Res,2002 ;62 (5):1567-1572
  • 4张卿,综述,胡成平.环氧化酶-2与肺癌研究进展[J].国外医学（生理病理科学与临床分册）,2004,24(5):422-424. 被引量：2
  • 5Devereaux QL,Takahashi R,Salvesen GS,et al.X-linked IAP is a direct inhibitor of cell death proteases[J].Nature,1997 ;388 (6639):300-304
  • 6Schroeder CP,Kadara H,Lotan D,et al.Involvement of mitochondrial and akt signaling pathways in augmented apoptosis induced by a combination of low doses of celecoxib and N-(4-hydroxyphenyl) retinamide in premalignant human bronchial epithelial cells[J].Cancer Res,2006 ;66(19):9762 -9770
  • 7刘俊茹,齐凤英,左连富,李丽,张玉军,郭建文,刘江惠.尼美舒利对人食管癌Eca-109细胞凋亡及Survivin和Caspase-3表达的影响[J].中国肿瘤临床,2006,33(1):16-19. 被引量：9
  • 8Swamy MV,Herzog CR,Rao CV.Inhibition of COX -2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53[J].Cancer Res,2003 ;63 (17):5239-5242
  • 9Hung WC,Chang HC,Pan MR,et al.Induction of P27(KIP1)as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells[J].Mol Pharmacol,2000;58(6):1398-1403
  • 10费素娟,陈光侠.尼美舒利抑制结肠癌细胞增殖及转移的机制[J].中国肿瘤临床,2006,33(9):497-499. 被引量：6

二级参考文献124

  • 1范跃祖,傅锦业,赵泽明,陈春球.去甲斑蝥素对人胆囊癌GBC-SD细胞系生长的影响及其机制探讨[J].肿瘤,2004,24(4):358-361. 被引量：8
  • 2孙现军,侯文红,马恒,王兴武,王永胜,徐忠法,姜希宏.选择性COX-2抑制剂Celecoxib对胃癌细胞增殖影响的探讨[J].中国肿瘤临床,2004,31(20):1171-1174. 被引量：6
  • 3刘莹,朱祖安,费素娟.COX-2 iNOS及VEGF在胃不典型增生胃癌中的表达及其意义[J].中国肿瘤临床,2005,32(8):428-430. 被引量：9
  • 4[1]Vane JR. The fight against rheumatism: from willow bark to COX-1sparing dmgs [J]. J Physiol Pharmacol, 2000, 51:573.
  • 5[2]Miyamoto T, Ogino N, Yanamoto S. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes [J]. J Biol Chem, 1976, 215:2629.
  • 6[3]Seibert K, Zhang Y, Leathy K. Distribution of COX-1 and COX-2 in normal and inflamed tissues [J]. Adv Exp Med Biol, 1997, 400A:167.
  • 7[4]Dewitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence [J]. Proc Natl Acad Sci USA, 1988, 85:1412.
  • 8[5]Vane JR, Bakhle YS, Botting RM. Cyclo-oxygenase-1 and 2 [J].Ann Rev Pharmacol Toxicol , 1998, 38:97.
  • 9[6]Mitchell JA, Akaraeereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinfalmmatory drugs as inhibitors of constitutive and inducible cyclooxygenase [J]. Proc Natl Acad Sci USA, 1994, 90:11693.
  • 10[7]Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroidal drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis [J].Proc Natl Acad Sci USA, 1999, 96:7563.

共引文献41

内蒙古医学院学报
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部